IP Verse

Aragon Pharmaceuticals, Inc. opposition analysis

COMPANY ANALYSIS

Latest patents of Aragon Pharmaceuticals, Inc. opposed by its competitors

Patent:
EP3226843
Grant Date:
May 26, 2021
Title:
Anticancer Compositions
Oppositions:
1
Patent:
EP3533792
Grant Date:
May 5, 2021
Title:
Crystalline Forms Of An Androgen Receptor Modulator
Oppositions:
1
Patent:
EP3226842
Grant Date:
Nov 25, 2020
Title:
Anticancer Compositions
Oppositions:
2
Patent:
EP3305285
Grant Date:
Sep 2, 2020
Title:
Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer
Oppositions:
3
Patent:
EP3348553
Grant Date:
Jul 8, 2020
Title:
Crystalline Forms Of An Androgen Receptor Modulator
Oppositions:
2
Patent:
EP2945628
Grant Date:
Apr 15, 2020
Title:
Androgen Receptor Modulator And Uses Thereof
Oppositions:
4
Patent:
EP2858985
Grant Date:
Apr 18, 2018
Title:
Crystalline Forms Of An Androgen Receptor Modulator
Oppositions:
3

Competitors of Aragon Pharmaceuticals, Inc.

GENERICS [UK] LIMITED

SANDOZ AG

SYNTHON BV

Want to track Aragon Pharmaceuticals, Inc.?

Feel free to send us a message here and we will get back to you